A novel pro-apoptotic function of RACK1: suppression of Src activity in the intrinsic and Akt pathways

V Mamidipudi1, C A Cartwright

  • 1Department of Medicine, Stanford University, Stanford, CA 94305-5187, USA.

Oncogene
|September 22, 2009
PubMed

Insights

Receptor for activated C kinase 1 (RACK1) inhibits human colon cell growth and triggers apoptosis by suppressing Src activity and blocking the Akt survival pathway. These findings suggest RACK1

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • RACK1 previously shown to regulate human colon cell growth by suppressing Src activity at G(1) and mitotic checkpoints.
  • RACK1's role in apoptosis and its precise molecular mechanisms in colon cells require further elucidation.

Purpose of the Study:

  • To investigate the role of RACK1 in inducing apoptosis in human colon cells.
  • To elucidate the molecular pathways, including Src and Akt signaling, involved in RACK1-mediated apoptosis.
  • To explore the potential of RACK1 as a therapeutic target in colon cancer.

Main Methods:

  • Analysis of RACK1's effects on apoptosis-related gene expression (Bcl-2, Bcl-X(L), Bim).
  • Mitochondrial pathway analysis: Bax and Bim targeting, Bax oligomerization, mitochondrial membrane depolarization, and cytochrome c release.
  • Assessment of caspase activation (caspase-9, caspase-3).
  • Investigation of RACK1's impact on the Akt cell survival pathway and FOXO3 activation.

Main Results:

  • RACK1 induces apoptosis in colon cells, partly by inhibiting Src.
  • RACK1 downregulates anti-apoptotic proteins (Bcl-2, Bcl-X(L)) and upregulates pro-apoptotic protein Bim.
  • RACK1 promotes mitochondrial cell death by targeting Bax and Bim to mitochondria, inducing Bax oligomerization, and releasing cytochrome c, leading to caspase activation.
  • RACK1 inhibits the Akt survival pathway, activating FOXO3, which contributes to apoptosis and G(1) arrest.
  • Bax and Bim are essential for RACK1-mediated mitochondrial cell death.

Conclusions:

  • RACK1 plays a dual role in colon cells: inhibiting growth and inducing apoptosis.
  • RACK1-mediated apoptosis occurs through intrinsic mitochondrial and extrinsic Akt/FOXO3 pathways, with Src inhibition being a common mechanism.
  • RACK1's ability to inhibit growth and induce death presents a promising strategy for developing novel colon cancer therapies.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...